Skip to content

Triggers and prediction of attacks in migraine: smartphone behaviour and E-diary

Triggers and prediction of attacks in migraine: smartphone behaviour and E-diary - Triggers and prediction of attacks in migraine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52185
Enrollment
500
Registered
2021-07-08
Start date
2022-07-27
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemicrania

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • At least be 18 years of age • Fulfil ICHD-III criteria for migraine • Patients must experience active migraine, which is defined for this study as at least 1 attack per month. • Willing to participate for at least 3 and for a maximum of 12 months

Exclusion criteria

Exclusion criteria: • Unable or unwilling to use (digital) headache dairy and smartphone behaviour app on a daily basis • Diagnosed with other (chronic) neurological diseases such as Parkinson*s disease, epilepsy etc. that may interfere with the results of this study. • Chronic migraine as defined by the ICHD-3 • Severe depression and/or panic disorders and/or schizophrenia and/or psychiatric disorders. • Inability to differentiate between migraine and other headache diagnoses. • Diagnosed with cluster headache or other TACs

Design outcomes

Primary

MeasureTime frame
(1) To identify the tappigraphical patterns correlating with migraine attacks as reported in the E-dairy and if tappigraphy can identify behavioural patterns preceding (early) signs of upcoming migraine attacks.

Secondary

MeasureTime frame
(1) To correlate patient-reported triggers to migraine attacks based on the E-diary; (2) To correlate E-diary recorded data for sleep with tappigraphical patterns.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)